Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
Status:
Recruiting
Trial end date:
2023-06-28
Target enrollment:
Participant gender:
Summary
The purpose of this first-in-man Phase I-IIa study is to evaluate the safety and antitumor
activity of autologous CD44v6 CAR T-cells in patients with acute myeloid leukemia (AML) and
multiple myeloma (MM).